Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.

Berg AH, Karumanchi SA, Thadhani R.

N Engl J Med. 2019 Jun 27;380(26):2584-2585. doi: 10.1056/NEJMc1905282. No abstract available.

PMID:
31242375
2.

Author Correction: Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA.

Nat Rev Nephrol. 2019 Jun;15(6):386. doi: 10.1038/s41581-019-0156-1.

PMID:
31068691
3.

The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.

Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, Cheung AK, Daugirdas JT, Greene T, Kovesdy CP, Miskulin DC, Thadhani RI, Winkelmayer WC, Ellenberg SS, Cifelli D, Madigan R, Young A, Angeletti M, Wingard RL, Kahn C, Nissenson AR, Maddux FW, Abbott KC, Landis JR.

J Am Soc Nephrol. 2019 May;30(5):890-903. doi: 10.1681/ASN.2018090945. Epub 2019 Apr 18.

PMID:
31000566
4.

Blood Microbiome Profile in CKD : A Pilot Study.

Shah NB, Allegretti AS, Nigwekar SU, Kalim S, Zhao S, Lelouvier B, Servant F, Serena G, Thadhani RI, Raj DS, Fasano A.

Clin J Am Soc Nephrol. 2019 May 7;14(5):692-701. doi: 10.2215/CJN.12161018. Epub 2019 Apr 8.

PMID:
30962186
5.

Vitamin D and Atherosclerotic Cardiovascular Disease.

Hiemstra T, Lim K, Thadhani R, Manson JE.

J Clin Endocrinol Metab. 2019 Apr 4. pii: jc.2019-00194. doi: 10.1210/jc.2019-00194. [Epub ahead of print]

PMID:
30946457
6.

Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.

Titan SM, Venturini G, Padilha K, Goulart AC, Lotufo PA, Bensenor IJ, Krieger JE, Thadhani RI, Rhee EP, Pereira AC.

PLoS One. 2019 Mar 18;14(3):e0213764. doi: 10.1371/journal.pone.0213764. eCollection 2019.

7.

Aiming Too Low: Reevaluation of Target Concentrations of Serum 25-Hydroxyvitamin D in Secondary Hyperparathyroidism.

Berg AH, Thadhani RI.

Am J Nephrol. 2019;49(4):281-283. doi: 10.1159/000499160. Epub 2019 Mar 15. No abstract available.

8.

1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.

Tavares G, Venturini G, Padilha K, Zatz R, Pereira AC, Thadhani RI, Rhee EP, Titan SMO.

Metabolomics. 2018 Feb 27;14(4):39. doi: 10.1007/s11306-018-1337-9.

PMID:
30830377
9.

Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA.

Nat Rev Nephrol. 2019 May;15(5):275-289. doi: 10.1038/s41581-019-0119-6. Review. Erratum in: Nat Rev Nephrol. 2019 Jun;15(6):386.

PMID:
30792480
10.

Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.

Olaniran KO, Eneanya ND, Allegretti AS, Zhao SH, Achebe MM, Thadhani RI.

Am J Nephrol. 2019;49(2):93-102. doi: 10.1159/000496058. Epub 2019 Jan 9.

PMID:
30625463
11.

Affordable Preeclampsia Therapeutics.

Lemoine E, Thadhani R.

Trends Pharmacol Sci. 2019 Feb;40(2):85-87. doi: 10.1016/j.tips.2018.12.007. Epub 2019 Jan 1.

PMID:
30609963
12.

Predicting the Future Is Not Difficult.

Cerdeira AS, Thadhani RI.

Hypertension. 2019 Jan;73(1):47-48. doi: 10.1161/HYPERTENSIONAHA.118.11931. No abstract available.

PMID:
30571566
13.

Sickle Cell Nephropathy in the Pediatric Population.

Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI.

Blood Purif. 2019;47(1-3):205-213. doi: 10.1159/000494581. Epub 2018 Dec 5. Review.

14.

Long-Term Anticoagulation for Patients Receiving Dialysis.

Nigwekar SU, Thadhani R.

Circulation. 2018 Oct 9;138(15):1530-1533. doi: 10.1161/CIRCULATIONAHA.118.037091. No abstract available.

PMID:
30354526
15.

Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate.

Hutchison A, Whelton A, Thadhani R, Achenbach H, Vergani A, Wu J, Hall G.

Nephron. 2018;140(4):265-274. doi: 10.1159/000492603. Epub 2018 Oct 23.

16.

The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Melamed ML, Chonchol M, Gutiérrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R.

Am J Kidney Dis. 2018 Dec;72(6):834-845. doi: 10.1053/j.ajkd.2018.06.031. Epub 2018 Oct 5.

PMID:
30297082
17.

Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.

de Boer IH, Zelnick LR, Lin J, Schaumberg D, Wang L, Ruzinski J, Friedenberg G, Duszlak J, Bubes VY, Hoofnagle AN, Thadhani R, Glynn RJ, Buring JE, Sesso HD, Manson JE.

Contemp Clin Trials. 2018 Nov;74:11-17. doi: 10.1016/j.cct.2018.09.014. Epub 2018 Sep 30.

PMID:
30282055
18.

Complement 7 Is Up-Regulated in Human Early Diabetic Kidney Disease.

Sircar M, Rosales IA, Selig MK, Xu D, Zsengeller ZK, Stillman IE, Libermann TA, Karumanchi SA, Thadhani RI.

Am J Pathol. 2018 Oct;188(10):2147-2154. doi: 10.1016/j.ajpath.2018.06.018.

PMID:
30253844
19.

Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.

Thadhani R, Guilatco R, Hymes J, Maddux FW, Ahuja A.

Am J Nephrol. 2018;48(3):214-224. doi: 10.1159/000492621. Epub 2018 Sep 7.

20.

Angiogenic biomarkers in triage and risk for preeclampsia with severe features.

Rana S, Salahuddin S, Mueller A, Berg AH, Thadhani RI, Karumanchi SA.

Pregnancy Hypertens. 2018 Jul;13:100-106. doi: 10.1016/j.preghy.2018.05.008. Epub 2018 May 25.

PMID:
30177034
21.

Metabolites related to eGFR: Evaluation of candidate molecules for GFR estimation using untargeted metabolomics.

Titan SM, Venturini G, Padilha K, Tavares G, Zatz R, Bensenor I, Lotufo PA, Rhee EP, Thadhani RI, Pereira AC.

Clin Chim Acta. 2019 Feb;489:242-248. doi: 10.1016/j.cca.2018.08.037. Epub 2018 Aug 25.

PMID:
30153452
22.

Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.

Allegretti AS, Vela Parada X, Ortiz GA, Long J, Krinsky S, Zhao S, Fuchs BC, Sojoodi M, Zhang D, Karumanchi SA, Kalim S, Nigwekar SU, Thadhani RI, Parikh SM, Chung RT.

Hepatology. 2019 Feb;69(2):729-741. doi: 10.1002/hep.30230. Epub 2019 Jan 4.

PMID:
30141205
23.

De novo NAD+ biosynthetic impairment in acute kidney injury in humans.

Poyan Mehr A, Tran MT, Ralto KM, Leaf DE, Washco V, Messmer J, Lerner A, Kher A, Kim SH, Khoury CC, Herzig SJ, Trovato ME, Simon-Tillaux N, Lynch MR, Thadhani RI, Clish CB, Khabbaz KR, Rhee EP, Waikar SS, Berg AH, Parikh SM.

Nat Med. 2018 Sep;24(9):1351-1359. doi: 10.1038/s41591-018-0138-z. Epub 2018 Aug 20.

24.

Health Literacy Mediates Racial Disparities in Cardiopulmonary Resuscitation Knowledge among Chronic Kidney Disease Patients.

Eneanya ND, Olaniran K, Xu D, Waite K, Crittenden S, Hazar DB, Volandes AE, Temel JS, Thadhani R, Paasche-Orlow MK.

J Health Care Poor Underserved. 2018;29(3):1069-1082. doi: 10.1353/hpu.2018.0080.

25.

Calciphylaxis in Patients With Normal Renal Function: A Case Series and Systematic Review.

Bajaj R, Courbebaisse M, Kroshinsky D, Thadhani RI, Nigwekar SU.

Mayo Clin Proc. 2018 Sep;93(9):1202-1212. doi: 10.1016/j.mayocp.2018.06.001. Epub 2018 Jul 27.

PMID:
30060958
26.

Calciphylaxis.

Nigwekar SU, Thadhani R, Brandenburg VM.

N Engl J Med. 2018 Jul 26;379(4):399-400. doi: 10.1056/NEJMc1807324. No abstract available.

PMID:
30044942
27.

Risk of Preeclampsia and Pregnancy Complications in Women With a History of Acute Kidney Injury.

Tangren JS, Wan Md Adnan WAH, Powe CE, Ecker J, Bramham K, Hladunewich MA, Ankers E, Karumanchi SA, Thadhani R.

Hypertension. 2018 Aug;72(2):451-459. doi: 10.1161/HYPERTENSIONAHA.118.11161. Epub 2018 Jun 18.

PMID:
29915020
28.

Association of Smoking Status With Mortality and Hospitalization in Hemodialysis Patients.

Li NC, Thadhani RI, Reviriego-Mendoza M, Larkin JW, Maddux FW, Ofsthun NJ.

Am J Kidney Dis. 2018 Nov;72(5):673-681. doi: 10.1053/j.ajkd.2018.04.004. Epub 2018 Jun 15.

PMID:
29909936
29.

The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.

Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, Betensky RA, Steinman TI, Thadhani RI, McMahon GM, Stillman IE, Rennke HG, Waikar SS.

J Am Soc Nephrol. 2018 Aug;29(8):2213-2224. doi: 10.1681/ASN.2017121260. Epub 2018 Jun 4.

PMID:
29866798
30.

Vitamin D and Calcimimetics in Cardiovascular Disease.

Lim K, Hamano T, Thadhani R.

Semin Nephrol. 2018 May;38(3):251-266. doi: 10.1016/j.semnephrol.2018.02.005. Review.

31.

Calciphylaxis.

Nigwekar SU, Thadhani R, Brandenburg VM.

N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292. Review. No abstract available.

PMID:
29719190
32.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

33.

Epidemiology: Chronic disease, cancer, and exercise - a common link.

Allegretti AS, Thadhani RI.

Nat Rev Nephrol. 2018 May;14(5):288-290. doi: 10.1038/nrneph.2018.24. Epub 2018 Mar 26. No abstract available.

PMID:
29578209
34.

Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions.

Trottier C, Perl J, Freeman M, Thadhani R, Berg A, Kalim S.

Perit Dial Int. 2018 Mar-Apr;38(2):149-152. doi: 10.3747/pdi.2017.00176.

PMID:
29563277
35.

UBD modifies APOL1-induced kidney disease risk.

Zhang JY, Wang M, Tian L, Genovese G, Yan P, Wilson JG, Thadhani R, Mottl AK, Appel GB, Bick AG, Sampson MG, Alper SL, Friedman DJ, Pollak MR.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3446-3451. doi: 10.1073/pnas.1716113115. Epub 2018 Mar 12.

36.

Metabolic and Hypertensive Complications of Pregnancy in Women with Nephrolithiasis.

Tangren JS, Powe CE, Ecker J, Bramham K, Ankers E, Karumanchi SA, Thadhani R.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):612-619. doi: 10.2215/CJN.12171017. Epub 2018 Feb 22.

37.

Response to the Letter to the Editor by Finsterer and Zarrouk-Mahjoub in Clin Nephrol Case Stud. 2018; 6: 1.

Lim K, Steele D, Fenves A, Thadhani R, Heher E, Karaa A.

Clin Nephrol Case Stud. 2018 Jan 16;6:2-3. doi: 10.5414/CNCS109366R. eCollection 2018.

38.

Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles.

Kalim S, Wald R, Yan AT, Goldstein MB, Kiaii M, Xu D, Berg AH, Clish C, Thadhani R, Rhee EP, Perl J.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):436-444. doi: 10.2215/CJN.08790817. Epub 2018 Feb 14.

39.

Urinary Stone Disease and Cardiovascular Disease Risk in a Rural Chinese Population.

Fan X, Kalim S, Ye W, Zhao S, Ma J, Nigwekar SU, Chan KE, Cui J, Cai J, Wang L, Heng W, Zhou Y, Sun Y, Cui R, Zhang W, Wang B, Dai Q, Li X, Thadhani R, Li X.

Kidney Int Rep. 2017 Jun 8;2(6):1042-1049. doi: 10.1016/j.ekir.2017.06.001. eCollection 2017 Nov.

40.

Acute Homeostatic Changes Following Vitamin D2 Supplementation.

Berg AH, Bhan I, Powe C, Karumanchi SA, Xu D, Thadhani RI.

J Endocr Soc. 2017 Jul 19;1(9):1135-1149. doi: 10.1210/js.2017-00244. eCollection 2017 Sep 1.

41.

Cerebroplacental ratio and fetal response to maternal extracorporeal soluble fms-like tyrosine kinase-1 removal.

Weber ML, Schaarschmidt W, Thadhani R, Stepan H.

Ultrasound Obstet Gynecol. 2018 Sep;52(3):405-406. doi: 10.1002/uog.18980. No abstract available.

PMID:
29226474
42.

Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis.

Lecarpentier E, Gris JC, Cochery-Nouvellon E, Mercier E, Touboul C, Thadhani R, Karumanchi SA, Haddad B.

Obstet Gynecol. 2018 Jan;131(1):63-69. doi: 10.1097/AOG.0000000000002380.

PMID:
29215518
43.

Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis.

Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, Thadhani RI, Malhotra R, Bloch DB.

Am J Nephrol. 2017;46(5):429-438. doi: 10.1159/000484418. Epub 2017 Nov 9.

44.

Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

Allegretti AS, Parada XV, Eneanya ND, Gilligan H, Xu D, Zhao S, Dienstag JL, Chung RT, Thadhani RI.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):16-25. doi: 10.2215/CJN.03610417. Epub 2017 Nov 9.

45.

Focal segmental glomerulosclerosis associated with mitochondrial disease.

Lim K, Steele D, Fenves A, Thadhani R, Heher E, Karaa A.

Clin Nephrol Case Stud. 2017 Mar 3;5:20-25. doi: 10.5414/CNCS109083. eCollection 2017.

46.

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.

Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1615-1623. doi: 10.2215/CJN.02510317. Epub 2017 Sep 7.

47.

Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.

Griessenauer CJ, Chua MH, Hanafy KA, Baffour YT, Chen R, LeBlanc RH 3rd, Patel AS, Salem M, Karumanchi SA, Xu D, Thadhani R, Ogilvy CS, Thomas AJ.

World Neurosurg. 2017 Dec;108:84-89. doi: 10.1016/j.wneu.2017.08.128. Epub 2017 Sep 1.

PMID:
28867315
48.

The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.

Smith WB, Gibson S, Newman GE, Hendon KS, Askelson M, Zhao J, Hantash J, Flanagan B, Larkin JW, Usvyat LA, Thadhani RI, Maddux FW.

BMC Nephrol. 2017 Aug 29;18(1):273. doi: 10.1186/s12882-017-0683-6.

49.

Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Nov;70(5):696-704. doi: 10.1053/j.ajkd.2017.06.029. Epub 2017 Aug 31.

PMID:
28838766
50.

Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.

Khedkar SA, Samad MA, Choudhury S, Lee JY, Zhang D, Thadhani RI, Karumanchi SA, Rigby AC, Kang PM.

Sci Rep. 2017 Aug 16;7(1):8427. doi: 10.1038/s41598-017-08670-y.

Supplemental Content

Loading ...
Support Center